Gary Stobbe1, Yajuan Liu2, Rebecca Wu3, Laura Heath Hudgings4, Owen Thompson5, Fuki M Hisama6. 1. 1] Department of Neurology, University of Washington, Seattle, Washington, USA [2] Department of Psychiatry, University of Washington, Seattle, Washington, USA. 2. Department of Pathology, University of Washington, Seattle, Washington, USA. 3. Department of Neurobiology, University of Washington, Seattle, Washington, USA. 4. Department of Family Medicine, University of Washington, Seattle, Washington, USA. 5. Department of Genome Sciences, University of Washington, Seattle, Washington, USA. 6. 1] Department of Neurology, University of Washington, Seattle, Washington, USA [2] Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA.
Abstract
PURPOSE: Array comparative genomic hybridization is available for the evaluation of autism spectrum disorders. The diagnostic yield of testing is 5-18% in children with developmental disabilities, including autism spectrum disorders and multiple congenital anomalies. The yield of array comparative genomic hybridization in the adult autism spectrum disorder population is unknown. METHODS: We performed a retrospective chart review for 40 consecutive patients referred for genetic evaluation of autism from July 2009 through April 2012. Four pediatric patients were excluded. Medical history and prior testing were reviewed. Clinical genetic evaluation and testing were offered to all patients. RESULTS: The study population comprised 36 patients (age range 18-45, mean 25.3 years). An autism spectrum disorder diagnosis was confirmed in 34 of 36 patients by medical record review. One patient had had an abnormal karyotype; none had prior array comparative genomic hybridization testing. Of the 23 patients with autism who underwent array comparative genomic hybridization, 2 of 23 (8.7%) had pathogenic or presumed pathogenic abnormalities and 2 of 23 (8.7%) had likely pathogenic copy-number variants. An additional 5 of 23 (22%) of autism patients had variants of uncertain significance without subclassification. CONCLUSION: Including one patient newly diagnosed with fragile X syndrome, our data showed abnormal or likely pathogenic findings in 5 of 24 (21%) adult autism patients. Genetic reevaluation in adult autism patients is warranted.
PURPOSE: Array comparative genomic hybridization is available for the evaluation of autism spectrum disorders. The diagnostic yield of testing is 5-18% in children with developmental disabilities, including autism spectrum disorders and multiple congenital anomalies. The yield of array comparative genomic hybridization in the adult autism spectrum disorder population is unknown. METHODS: We performed a retrospective chart review for 40 consecutive patients referred for genetic evaluation of autism from July 2009 through April 2012. Four pediatric patients were excluded. Medical history and prior testing were reviewed. Clinical genetic evaluation and testing were offered to all patients. RESULTS: The study population comprised 36 patients (age range 18-45, mean 25.3 years). An autism spectrum disorder diagnosis was confirmed in 34 of 36 patients by medical record review. One patient had had an abnormal karyotype; none had prior array comparative genomic hybridization testing. Of the 23 patients with autism who underwent array comparative genomic hybridization, 2 of 23 (8.7%) had pathogenic or presumed pathogenic abnormalities and 2 of 23 (8.7%) had likely pathogenic copy-number variants. An additional 5 of 23 (22%) of autism patients had variants of uncertain significance without subclassification. CONCLUSION: Including one patient newly diagnosed with fragile X syndrome, our data showed abnormal or likely pathogenic findings in 5 of 24 (21%) adult autism patients. Genetic reevaluation in adult autism patients is warranted.
Authors: Bo Zhou; Steve S Ho; Xianglong Zhang; Reenal Pattni; Rajini R Haraksingh; Alexander E Urban Journal: J Med Genet Date: 2018-07-30 Impact factor: 6.318
Authors: Mohammed Uddin; Bhooma Thiruvahindrapuram; Susan Walker; Zhuozhi Wang; Pingzhao Hu; Sylvia Lamoureux; John Wei; Jeffrey R MacDonald; Giovanna Pellecchia; Chao Lu; Anath C Lionel; Matthew J Gazzellone; John R McLaughlin; Catherine Brown; Irene L Andrulis; Julia A Knight; Jo-Anne Herbrick; Richard F Wintle; Peter Ray; Dimitri J Stavropoulos; Christian R Marshall; Stephen W Scherer Journal: Genet Med Date: 2014-12-11 Impact factor: 8.822
Authors: Francesco Paduano; Emma Colao; Sara Loddo; Valeria Orlando; Francesco Trapasso; Antonio Novelli; Nicola Perrotti; Rodolfo Iuliano Journal: Genes (Basel) Date: 2020-05-08 Impact factor: 4.096